Urticarial Vasculitis (UV)
ð āļิāļĒāļēāļĄāļŠāļģāļัāļ
UV =
1. āļāļēāļāļēāļĢāļāļĨิāļิāļāđāļāļ urticaria
(wheals, angioedema) āđāļ่…
2. āļĄี leukocytoclastic
vasculitis (LCV) āđāļ skin biopsy
āļัāļāđāļ็āļ clinicopathologic diagnosis
āļ้āļāļāļĄีāļั้āļāļāļēāļāļēāļĢāļิāļ§āļŦāļัāļ āđāļĨāļ° āļŦāļĨัāļāļāļēāļ vasculitis āļึāļāļ§ิāļิāļāļัāļĒāđāļ้
ð§Ž āļāļēāļĢāļāļģāđāļāļ
(āļŠāļģāļัāļāļ่āļāļāļĒāļēāļāļĢāļ์āđāļĢāļ)
|
āļāļĢāļ°āđāļ āļ |
Complement |
āļāļ§āļēāļĄāļĢุāļāđāļĢāļ / Systemic
involvement |
|
Normocomplementemic UV (NUV) |
āļāļāļิ |
āļĄัāļāļāļģāļัāļāļี่āļิāļ§āļŦāļัāļ
āļีāļึ้āļāđāļāļāđāļ้ |
|
Hypocomplementemic UV (HUV) |
↓
C3, C4, C1q |
āļิāļ§āļŦāļัāļ ±
systemic involvement āđāļĨ็āļāļ้āļāļĒ |
|
Hypocomplementemic UV Syndrome
(HUVS) |
↓
complement āļĄāļēāļ āđāļāļĒāđāļāļāļēāļ° C1q (+ anti-C1q) |
Systemic vasculitis āļัāļāđāļāļ: arthritis, glomerulonephritis, uveitis, pulmonary
disease |
HUVS = UV + hypocomplementemia + systemic vasculitis ≥6
āđāļืāļāļ
ð§ Pathophysiology
- Immune
complex-mediated small vessel vasculitis
- āļāļĨāļēāļŠāļŠิāļ → activation of classical complement pathway
- ↓C3 ↓C4 ↓C1q
- āļāļģāđāļāļŠู่:
- C3a/C5a
→ mast cell
degranulation →
urticaria
- Neutrophil
infiltration → vessel
damage → purpura,
pain, edema
- āļāļēāļāļĢāļēāļĒāļāļ Anti-C1q antibody (āđāļ่āļāđāļ HUVS)
ð§Ŧ Histopathology hallmark
- Leukocytoclastic
vasculitis
- Neutrophils
+ nuclear dust
- Fibrinoid
necrosis
- RBC
extravasation
- DIF:
Ig/complement deposits perivascular
(āđāļĄ่āļāļģāđāļāļēāļ° → SLE āļ็āļāļāđāļ้)
ð āļุāļāļāļģāđāļāļāļāļēāļ
chronic urticaria = Leukocytoclasia + RBC extravasation
ð§♀️ Clinical
presentation
āļิāļ§āļŦāļัāļ
āļĨัāļāļĐāļāļ°āļี่āļ่āļ§āļĒāđāļĒāļāļāļēāļ chronic urticaria
|
Feature |
UV |
Ordinary urticaria |
|
Duration of lesion |
>24–72 āļāļĄ. |
<24 āļāļĄ. |
|
Pain/burning |
āļāļāļ่āļāļĒ |
āđāļ่āļัāļ |
|
Residual purpura/bruising |
āļāļāļ่āļāļĒ |
āđāļĄ่āļāļ |
|
Post-inflammatory
hyperpigmentation |
āļāļāđāļ้ |
āđāļĄ่āļāļ |
āđāļิ่āļĄāđāļิāļĄ:
- Angioedema
~40–50%
- Livedo
reticularis, purpura āļāļāđāļ้
Systemic involvement
āļāļāļ่āļāļĒāđāļ HUV/HUVS:
- MSK:
migratory arthritis/arthralgia
- Pulmonary:
COPD-like, dyspnea, hemoptysis →
āļŠāļģāļัāļāļŠุāļāđāļĢื่āļāļmortality
- Renal:
hematuria/proteinuria; GN
- GI:
pain, nausea
- Eye:
uveitis, episcleritis
- Neuro:
pseudotumor cerebri, neuropathy
ð āļāļēāļĢāļāļĢāļ§āļāļāļēāļāļŦ้āļāļāļāļิāļัāļิāļāļēāļĢ
āļāļ§āļĢāļāļģāđāļĄื่āļ biopsy confirm LCV + āļŠāļāļŠัāļĒ UV
- Complement
(C3, C4, C1q, CH50) →
āļัāļ§āļี้ severity
- ANA,
anti-dsDNA, ENA panel →
āđāļĒāļ SLE/SjÃķgren
- CBC,
ESR
- Urinalysis,
Cr/BUN → kidney
involvement
- HBV,
HCV serologies
- Anti-C1q
(āļ้āļēāļĄี) → āļ่āļ§āļĒāđāļĒāļ HUVS
āļื่āļāđ āļāļēāļĄ organ involvement:
- CXR/CT
chest + PFT →
pulmonary
- Echo → valvular disease āđāļ HUVS
ð§ Differential Diagnosis
|
āđāļĢāļ |
āđāļĒāļāļāļēāļ UV |
|
Chronic spontaneous urticaria
(CSU) |
āđāļĄ่āļĄี LCV /
lesion āļŦāļēāļĒ <24 āļāļĄ. / complement āļāļāļิ |
|
EM minor |
target lesions, mucosa +/- |
|
Acquired C1-inhibitor deficiency |
āđāļĄ่āļĄี urticaria |
|
Neutrophilic urticarial
dermatosis |
āđāļĄ่āļĄี vasculitis,
lesion <24 āļāļĄ. |
|
Schnitzler syndrome |
IgM gammopathy, IL-1 mediated |
ð āļāļēāļĢāļĢัāļāļĐāļē
— āļāļēāļĄāļāļ§āļēāļĄāļĢุāļāđāļĢāļāđāļĨāļ° organ involvement
Mild (āļิāļ§āļŦāļัāļ ± arthralgia)
- Antihistamine
(āļ่āļ§āļĒāļัāļ āđāļĄ่āļĨāļ vasculitis)
- NSAIDs
āļŠāļģāļŦāļĢัāļ joint pain (āļĒāļāđāļ§้āļāļĄี renal
involvement)
Moderate (skin + systemic involvement āļāļēāļāļŠ่āļ§āļ)
- Systemic
glucocorticoids
Prednisone 0.5–1 mg/kg/day - Steroid-sparing
agents
- Dapsone
(āļāļĢāļ§āļ G6PD āļ่āļāļ)
- Colchicine
- Hydroxychloroquine
ð āļāļ§āļĢ taper
steroid āļ้āļē āđāļĨāļ° monitor relapse
Severe systemic disease / Organ-threatening
⚠ āļāļ§āļĢ consult
Rheumatology/Dermatology
āļัāļ§āđāļĨืāļāļ:
- Mycophenolate
mofetil
- Azathioprine
- Cyclosporine
A
- Methotrexate
- Cyclophosphamide
(rare)
- Biologics
āđāļ่āļ
- Rituximab
- Anakinra
/ Canakinumab (IL-1 inhibitors)
- Omalizumab
(case reports)
ð āļāļĒāļēāļāļĢāļ์āđāļĢāļ
|
Subtype |
Prognosis |
|
NUV |
āļี
āļŠ่āļ§āļāđāļŦāļ่āļāļģāļัāļāļี่āļิāļ§āļŦāļัāļ |
|
HUV/HUVS |
āđāļĢāļāļĒāļēāļ§ 3–4 āļีāļŦāļĢืāļāļĄāļēāļāļāļ§่āļē; morbidity āļŠูāļ āđāļāļĒāđāļāļāļēāļ° āļāļāļ |
ð āļŠāļēāđāļŦāļุāļāļēāļĢāđāļŠีāļĒāļีāļ§ิāļāļāļāđāļ้āļāļēāļ
→ Pulmonary disease
(COPD/emphysematous changes)
āđāļĨāļ° rare →
laryngeal edema
ð Clinical Pearls
(Bedside)
- āđāļāļāļāđāļ้ “urticaria >24 āļāļĄ. + painful
+ purpura” → āļ้āļāļāļŠ่āļ biopsy
- āļ้āļēāļĄี hematuria/proteinuria →
assess complement āđāļĨāļ°āļŠ่āļ nephrology
- āļ้āļēāļĄี COPD āļี่āļāļิāļāļēāļĒāđāļĄ่āđāļ้ → āļิāļāļึāļ
UV/HUVS
- Anti-C1q
antibody → āļŠāļัāļāļŠāļุāļ HUVS āđāļ่āđāļĄ่āļāļģāđāļ็āļāļ่āļ diagnosis
āđāļĄ่āļĄีāļāļ§āļēāļĄāļิāļāđāļŦ็āļ:
āđāļŠāļāļāļāļ§āļēāļĄāļิāļāđāļŦ็āļ